NHS will be ‘unrecognisable’ in 10 years’ time, say doctors
April 16, 2007NHS
Most young doctors believe the NHS will be unrecognisable in 10 years' time, a new survey has revealed.The research, published …
Europe imposes restrictions on Ketek prescribing
April 16, 2007Sales and Marketing Ketek, safety
The European Medicines Agency has issued guidance for the four indications of Ketek, the Sanofi-Aventis antibiotic stripped of several indications …
Encouraging New Thinking in Strategic Planning
April 12, 2007Sales and Marketing marketing, planning, strategic planning, strategy
How many pharma marketers, faced with the annual chore of writing a strategic plan, have decided not to take the …
Product Development Update
April 12, 2007Research and Development, Sales and Marketing
Product news round-up from Datamonitor ChemGenex begins CML trialChemGenex Pharmaceutical has treated the first patient in a new phase II/III clinical …
Change in US law could cut drugs spending by $30 billion
April 12, 2007Sales and Marketing US, reform
Calls to allow the US government to negotiate drug prices with the pharmaceutical industry have been reawakened by a new …
Abbott lowers prices on HIV drugs
April 12, 2007Sales and Marketing HIV, par
Intervention from the World Health Organisation has spurred Abbott to lower its prices on HIV drugs in developing countries.The company …
Resolute to open New York office
April 12, 2007Medical Communications Resolute
London-based healthcare consultancy Resolute is to break into the all-important US market by opening an office in New York.Resolute was …
Sales representatives blow the whistle on rule-breaking call rates
April 11, 2007Sales and Marketing ABPI, ethics
Pharmaceutical sales representatives are turning to the industry regulator and blowing the whistle on their own companies, when they are …
Novartis’ Zelnorm pulled from market after safety concerns
April 2, 2007Sales and Marketing FDA, reg
Zelnorm, the treatment for irritable bowel syndrome, has been withdrawn from the US market after the FDA raised concerns about …
Helping marketers shape up for the job
April 2, 2007Business Services, Sales and Marketing PRIME, marketing, pm society, recruitment, training
Marketing is defined in the New English Dictionary as all the processes involved in moving goods from the producer to …
World news roundup
March 30, 2007Sales and Marketing
Crucell partners with ADImmune on flu vaccineDutch biotechnology company Crucell and Taiwanese-based ADImmune are to collaborate on an influenza vaccine …
US news roundup
March 30, 2007Sales and Marketing
Avicena starts phase III Parkinson's trialAvicena Group said that the National Institute of Neurological Disorders and Stroke (NINDS) has initiated …
Pfizer’s torcetrapib results cast doubt on CETP inhibitors
March 30, 2007Research and Development, Sales and Marketing Pfizer, lipid
New data on Pfizer's ill-fated torcetrapib suggest the drug doesn't reduce arterial plaque, casting doubt on other drugs in the …
Oxford BioMedica’s biotech buy adds to its cancer vaccine pipeline
March 29, 2007Sales and Marketing
Oxford BioMedica has expanded its product pipeline with the £16 million acquisition of fellow Oxford-based biotech Oxxon Therapeutics.The deal gives …
S-P and Merck to develop Lipitor combination
March 29, 2007Sales and Marketing cv
Schering-Plough and Merck have announced plans to develop a new 2-in-1 cholesterol pill that would include Lipitor, which belongs to …
Post-Northwick Park European guidelines out for consultation
March 26, 2007Research and Development phase I
European regulators have produced draft guidance for phase I research, designed to minimise the risk of a repeat of the …
Judicial review on Alzheimer’s drugs to go ahead
March 26, 2007Sales and Marketing
The decision to restrict access to Alzheimer's drugs for some patients is to be scrutinised in a UK court, it …
HIV market: collaborative combinations
March 26, 2007Research and Development, Sales and Marketing HIV, drug development, marketing
Two new HIV drugs, from Tibotec and Gilead, have been shown to be viable late-stage pipeline candidates. However, both TMC278 …
You have 6 new messages
March 26, 2007Medical Communications, Sales and Marketing e-marketing, marketing, marketing mix, new media
What are the biggest challenges in 2007 for e-marketing?Overexposure of e-detailing gave a poor response in many cases in 2006 …
Diabetes UK report criticises cutbacks in NHS
March 23, 2007diabetes
In a new report, Diabetes UK has criticised cutbacks in NHS diabetes treatment, suggesting that service reductions are putting patients' …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
